SIR,-Mr H C Wilkes and Dr T W Meade have estimated the rate of prescribing of hormone replacement therapy in general practice. ' We have obtained data on prescribing of hormone replacement therapy during January to June 1990 to women born betwen 1921 and 1940 registered with 165 practices with computers supplied by VAMP Health (which met minimum criteria for completeness and internal consistency of data during this period). These data indicate that 8-2% of women received at least one prescription for hormone replacement therapy (2-9% oestrogen therapy, 5-3% combined therapy) and confirm that hormone replacement therapy, particularly combined therapy, is becoming increasingly common in the United Kingdom (H Jick, personal communication).
Important questions about the long term risks and benefits associated with hormone replacement therapy remain. In particular, does the addition of progestogen (usually given to prevent endometrial hyperplasia induced by oestrogen in women who have not had a hysterectomy) negate the beneficial effects of oestrogen on cardiovascular disease? If so there would be dramatic changes in the risk-benefit equations.2 Certainly, epidemiological evidence, albeit from our experience with combined oral contraceptives,3 and theoretical evidence from biochemical changes4 suggest that this may be the case.
Randomised, blind clinical controlled trials would ideally provide the answer. These, unfortunately, are neither practical nor ethical. In women who have not had a hysterectomy blinding cannot occur: doctors would need to ask women in the trial about patterns of bleeding to detect those randomised to receive unopposed oestrogen who subsequently developed endometrial hyperplasia; women receiving oestrogen-progestogen preparations would report regular monthly bleeding. A similar trial in women who have had a hysterectomy must be unethical as those randomised to receive opposed oestrogen would at best be receiving a preparation with no additional risks or benefits or, more probably, would receive a drug with a decidedly worse risk profile.The third option, in which one group receives hormone replacement therapy and one does not, may pose fewer ethical problems as at least none of the patients would be given a drug that is potentially harmful, but we believe that few women would give informed consent to participate.
Considering the problems associated with controlled trials, we believe that a long term cohort study is needed in the United Kingdom. Similar British cohort studies of women using oral contraceptives have proved to be of major public health importance and benefit. Although differences between women receiving and not receiving hormone replacement therapy, in terms of confounding factors, may be greater than those between women using and not using oral contraceptives, the problem of adjusting for these differences is not insurmountable. At least three established research groups in the United Kingdom have proposed cohort studies but have failed to be funded. The prevalence of prescribing is now such that a cohort of women receiving hormone replacement therapy of sufficient size (15 000-20 000) could easily be recruited. Furthermore, the availability of computerised data may make the recruitment and follow up of these women easier. We urge the relevant funding bodies to fund at least one such cohort study. Medical or surgical orchidectomy? SIR, -Dr H Parmar and colleagues take us to task for not having mentioned their study, which was a randomised controlled study of an analogue of luteinising hormone releasing hormone versus orchidectomy in advanced prostatic cancer.' The purpose of our paper2 was to report the patients' choice of treatment given the fact that there is to date no statistically significant difference between the two treatments. Dr Parmar and colleagues' patients, however, were not given this choice of treatment as they were randomised, and we therefore consider their remarks to be irrelevant. Preventing needlestick injuries SIR,-Professor D C Anderson and colleagues promote resheathing as a safe means ofdisposing of needles.' They quote a study of Jagger et al, in which 52 of 86 injuries caused by used disposable needles occurred during or after recapping.2 Examining the circumstances of each injury, they concluded that "even with an intrinsically unsafe routine technique, resheathing may prevent as many injuries as it causes." Jagger et al, however, recorded only the total number of injuries caused by recapping versus not recapping. No indication was given of the proportion of needles that were recapped. It is therefore impossible to say whether recapping is a fairly safe means of disposal causing many injuries because it is performed by many workers or whether it is highly dangerous but practised by only a few. Without this information it is not possible to make reliable recommendations on which technique should be adopted. Jagger et al attempted to infer a risk by assuming "various baseline rates of recapping" of the 1 657 000 needles purchased during the study,3 but this gives only theoretical rates so long as the actual rate of recapping is unknown.
We circulated questionnaires to 275 medical students, of whom 172 (66%) responded. The injury rates among those who did and did not recap needles were not significantly different (p>005; power 77%). We note that the two populations were self selected. These data suggest, however, that for students who practise their preferred technique there is not a significant difference in the rate of injury. ROBIN 
